Full text is available at the source.
Abstract
CRISPR-Cas9 has enabled efficient modification of DNA sequences through programmable guide RNAs (gRNAs).
- gRNAs are now seen as critical for determining both the effectiveness and accuracy of genome editing.
- Chemical modifications and sequence optimizations of gRNAs can improve their on-target performance while reducing unwanted effects.
- Artificial intelligence and machine learning enhance the design of gRNAs by increasing predictive accuracy through data analysis.
- An integrated framework is proposed to connect the molecular design of gRNAs with their potential clinical applications in therapeutic genome editing.
Simplified